Display Settings:

Format

Send to:

Choose Destination
    Presse Med. 2008 Nov;37(11):1676-82. Epub 2008 Sep 24.

    [Auto-inflammatory syndromes and pregnancy].

    [Article in French]

    Source

    Service de Médecine Interne, Centre de Référence des Amyloses d'Origine Inflammatoire et de la Fièvre Méditerranéenne Familiale, Hôpital Tenon, Assistance Publique-Hôpitaux de Paris, Université Paris 6, Paris Cedex 20, France. katia.stankovic@tnn.aphp.fr

    Abstract

    In familial mediterranean fever (FMF), fertility is normal in treated patients. There is no abnormality of spermatogenesis under usual therapeutic doses of colchicine. The risk of early abortion is increased if inflammatory attacks occur during the pregnancy. It is recommended to continue colchicine treatment during the conception and the pregnancy. Careful follow-up must be organized, even more in patients with renal amyloidosis. Breast-feeding is allowed under colchicine with no risk for the baby. There is no indication for systematic amniocentesis in FMF patients treated with colchicine.

    PMID:
    18818048
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Masson (France)

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk